Curevac N.V. (NQ: CVAC )
3.220
+0.010
(+0.31%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 29, 2024
Add to My Watchlist
Headline News about Curevac N.V.
![](https://g.foolcdn.com/editorial/images/631407/gettyimages-1239286866.jpg)
![](https://g.foolcdn.com/editorial/images/631218/covid-vaccine-with-dollar-sign.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/covid-19_vaccine_photo_by_daniel_schludi_on_unsplash_13.jpg)
![](https://g.foolcdn.com/editorial/images/631060/gettyimages-1313915798.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_227.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_346.jpg)
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs
June 20, 2021
Via Benzinga
Exposures
Product Safety
![](https://www.investors.com/wp-content/uploads/2018/04/stock-Federal-Reserve-06-adobe.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_388.png)
![](https://g.foolcdn.com/editorial/images/631087/gettyimages-scientist_computer_others-in-background.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_226.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/diana-polekhina-bufafc4l8v0-unsplash_0.jpg)
Tesla Partner CureVac Says Will Find 'Sweet Spot' For COVID-19 Vaccine Despite Disappointing Data
June 18, 2021
Via Benzinga
Exposures
COVID-19
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2021/june/mmc/mmc-stats-617.jpg?sfvrsn=2ff9d706_2)
Dow Plummets as Fed Update, Jobless Data Weighs
June 17, 2021
Via Talk Markets
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://g.foolcdn.com/editorial/images/631014/elderly-covid-patient.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://www.investors.com/wp-content/uploads/2021/01/Stock-CureVac-01-shutt.jpg)
Exposures
COVID-19
![](https://investorplace.com/wp-content/uploads/2020/08/cvac-stock-1.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_387.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/covid-19_corona-5174671_1920__image_by_gerd_altmann_from_pixabay__0.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://www.investors.com/wp-content/uploads/2020/04/Stock-Covid19-vaccine-04-adobe.jpg)
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_219.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.